Align Technology Inc(ALGN)
USD --+0.00%
Reward56Moderate
Risk32Moderate
📊75%Data
ALGN
+0.0 · +0.00%
USD · NASDAQ
Align Technology Inc | Healthcare
Quality Compounder
Market Cap:12.78Bn
ℹ️
Reward Rating
56
Moderate
Bottom 50% (model universe)
75% data coverage
ℹ️
Risk Rating
32
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on ALGN to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $206.86.

What is Align Technology Inc?

provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally.

ALGN · Verdict

Solid reward · moderate risk

ALGN stands out on balance sheet and cash flow, but watch the volatility signal.

Based on 88% data coverage

ALGN · Verdict

What’s working & what to watch

Strengths 3

  • Balance sheet88/100

    Current ratio 1.36

  • Cash flow82/100

    12% free-cash-flow margin

  • Valuation73/100

    P/E 15.7× · PEG 0.94

Watchouts 1

  • Volatility20/100

    Weak vs peers

Model-based scoring. For information only — not financial advice.

What is Align Technology Inc?

provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 12.78B, and a P/E ratio of 29.9x.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Adequate profitability with some margin variability in recent periods.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: Moderate (56)

The scoring profile indicates moderate reward potential, with valuation and profitability as the leading contributors. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap12.78B
P/E Ratio29.9329
Dividend YieldN/A
52 Week High208.31
52 Week Low122
Last AnnualDecember
IPO Date1/26/2001
IncorporatedUSA
Shares Outstanding72M
No. of Employees20,290
IndustryMedical Instruments & Supplies
ExchangeNASDAQ
Beta1.811
CurrencyUSD